Position Statement: Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer
27 Aug, 2019 | 00:25h | UTCRelated: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)
Related: Immune Checkpoint Inhibitor Toxicities (free guidelines and reviews on the subject)